Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
Rhea-AI Summary
Harrow (Nasdaq: HROW) will report second quarter 2026 financial results for the period ended June 30, 2026, after the market close on Monday, August 10, 2026. The company will post its Letter to Stockholders and host a conference call and webcast at 8:00 a.m. ET on Tuesday, August 11, 2026, with replay available on its investor website for one year.
Positive
- None.
Negative
- None.
News Market Reaction – HROW
In the Jul 27 session, HROW declined 2.57%, reflecting a moderate negative market reaction. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 27 | earnings date notice | Neutral | +4.3% | Announced first-quarter results date and next-day conference call schedule |
| Feb 18 | earnings date notice | Neutral | -1.3% | Announced fourth-quarter and year-end results date and conference call schedule |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The two prior earnings-date notices produced mixed 24-hour reactions, ranging from 4.31% higher to 1.33% lower, with an average move of 1.49%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 11, 2026
NASHVILLE, Tenn., July 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the second quarter ended June 30, 2026, on Monday, August 10, 2026, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, August 11, 2026, to discuss the results and provide a business update.
Conference Call Information
Participants can access the live webcast of Harrow’s presentation on the “Investors” page of Harrow’s website. A replay of the webcast will be available on the Company’s website for one year.
To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.
Contact:
Mike Biega
VP of Investor Relations & Communications
mbiega@harrowinc.com
617-913-8890
